Login
Evidence Feed
About
Diagnostics
New
Top genes
FAQ
Contact us
^
Login
Contact us
to learn more about
our Premium Content: News alerts, weekly reports and conference planners
BIOMARKER:
MYC overexpression + BCL2 overexpression
i
Other names:
MYC rearrangement-BCL2 rearrangement
Contact us
to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Entrez ID:
4609
;
596
Related biomarkers:
Expression
Mutation
CNA
Fusion
Others
‹
MYC amplification (29)
MYC amplification + HER-2 amplification (1)
BCL2 amplification (1)
MYC amplification (29)
MYC amplification + HER-2 amplification (1)
BCL2 amplification (1)
›
Associations
News
Trials
VERI cancer hierarchy
Reset Filters
MYC overexpression + BCL2 overexpression
Diffuse Large B Cell Lymphoma
MYC overexpression + BCL2 overexpression
Diffuse Large B Cell Lymphoma
ibrutinib
Sensitive: B - Late Trials
ibrutinib
Sensitive
:
B
ibrutinib
Sensitive: B - Late Trials
ibrutinib
Sensitive
:
B
MYC overexpression + BCL2 overexpression
Diffuse Large B Cell Lymphoma
MYC overexpression + BCL2 overexpression
Diffuse Large B Cell Lymphoma
axicabtagene ciloleucel
Sensitive: C3 – Early Trials
axicabtagene ciloleucel
Sensitive
:
C3
axicabtagene ciloleucel
Sensitive: C3 – Early Trials
axicabtagene ciloleucel
Sensitive
:
C3
MYC overexpression + BCL2 overexpression
Diffuse Large B Cell Lymphoma
MYC overexpression + BCL2 overexpression
Diffuse Large B Cell Lymphoma
Sensitive: C3 – Early Trials
Sensitive
:
C3
Sensitive: C3 – Early Trials
Sensitive
:
C3
MYC overexpression + BCL2 overexpression
Diffuse Large B Cell Lymphoma
MYC overexpression + BCL2 overexpression
Diffuse Large B Cell Lymphoma
azacitidine oral
Sensitive: C3 – Early Trials
azacitidine oral
Sensitive
:
C3
azacitidine oral
Sensitive: C3 – Early Trials
azacitidine oral
Sensitive
:
C3
MYC overexpression + BCL2 overexpression
Diffuse Large B Cell Lymphoma
MYC overexpression + BCL2 overexpression
Diffuse Large B Cell Lymphoma
doxorubicin hydrochloride + chidamide
Sensitive: D – Preclinical
doxorubicin hydrochloride + chidamide
Sensitive
:
D
doxorubicin hydrochloride + chidamide
Sensitive: D – Preclinical
doxorubicin hydrochloride + chidamide
Sensitive
:
D
MYC overexpression + BCL2 overexpression
Diffuse Large B Cell Lymphoma
MYC overexpression + BCL2 overexpression
Diffuse Large B Cell Lymphoma
CG-806
Sensitive: D – Preclinical
CG-806
Sensitive
:
D
CG-806
Sensitive: D – Preclinical
CG-806
Sensitive
:
D
MYC overexpression + BCL2 overexpression
Diffuse Large B Cell Lymphoma
MYC overexpression + BCL2 overexpression
Diffuse Large B Cell Lymphoma
venetoclax + CG-806
Sensitive: D – Preclinical
venetoclax + CG-806
Sensitive
:
D
venetoclax + CG-806
Sensitive: D – Preclinical
venetoclax + CG-806
Sensitive
:
D
^
^
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login